Abstract
Purpurogallin (PPG) has been demonstrated to exert an anti-inflammatory function in neurological diseases. This study aimed at investigating the role of PPG on microglial polarization post ischemic stroke as well as the underlying mechanism. Mouse hippocampal neurons HT-22 and microglial BV2 cells were treated by oxygen and glucose deprivation to simulate an in-vitro ischemia model. qRT-PCR and ELISA examined expression of cytokines in microglia. CCK8 and flow cytometry measured HT-22 cell viability and apoptosis, respectively. The levels of miR-124-3p and TRAF6/NF-κB were determined. A mouse cerebral ischemia model was set up using middle cerebral artery occlusion (MCAO) method. After being dealt with PPG, the neurological functions, brain edema, neuronal apoptosis, and microglia activation of the mice were evaluated. As suggested by the results, PPG transformed “M1” to “M2” polarization of BV2 cells, and abated HT-22 cell apoptosis. PPG enhanced the neurological functions, alleviated brain edema, and decreased neuroinflammatory responses, and neuronal apoptosis in the brain lesions of MCAO mice. Furthermore, PPG enhanced miR-124-3p and repressed the TRAF6/NF-κB pathway. miR-124-3p suppressed the TRAF6/NF-κB pathway by targeting TRAF6. Collectively, PPG alleviates ischemia-induced neuronal damage and microglial inflammation by modulating the miR-124-3p/TRAF6/NF-κB pathway.
Similar content being viewed by others
Data Availability
The data sets used and analyzed during the current study are available from the corresponding author on reasonable request.
References
Boursin P, Paternotte S, Dercy B, Sabben C, Maïer B (2018) Sémantique, épidémiologie et sémiologie des accidents vasculaires cérébraux [Semantics, epidemiology and semiology of stroke]. Soins 63(828):24–27. https://doi.org/10.1016/j.soin.2018.06.008 (French)
Jin R, Yang G, Li G (2010) Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 87(5):779–789. https://doi.org/10.1189/jlb.1109766
Liu M, Xu Z, Wang L, Zhang L, Liu Y, Cao J, Fu Q, Liu Y, Li H, Lou J, Hou W, Mi W, Ma Y (2020) Cottonseed oil alleviates ischemic stroke injury by inhibiting the inflammatory activation of microglia and astrocyte. J Neuroinflamm 17(1):270. https://doi.org/10.1186/s12974-020-01946-7
Liu ZJ, Ran YY, Qie SY, Gong WJ, Gao FH, Ding ZT, Xi JN (2019) Melatonin protects against ischemic stroke by modulating microglia/macrophage polarization toward anti-inflammatory phenotype through STAT3 pathway. CNS Neurosci Ther 25(12):1353–1362. https://doi.org/10.1111/cns.13261
Zhen AX, Piao MJ, Hyun YJ, Kang KA, Ryu YS, Cho SJ, Kang HK, Koh YS, Ahn MJ, Kim TH, Hyun JW (2019) Purpurogallin protects keratinocytes from damage and apoptosis induced by ultraviolet B radiation and particulate matter 2.5. Biomol Ther 27(4):395–403. https://doi.org/10.4062/biomolther.2018.151
Zeng LH, Wu TW (1992) Purpurogallin is a more powerful protector of kidney cells than Trolox and allopurinol. Biochem Cell Biol 70(8):684–690. https://doi.org/10.1139/o92-104
Wu TW, Wu J, Zeng LH, Au JX, Carey D, Fung KP (1994) Purpurogallin: in vivo evidence of a novel and effective cardioprotector. Life Sci 54(2):PL23–PL28
Wu TW, Zeng LH, Wu J, Carey D (1991) Purpurogallin—a natural and effective hepatoprotector in vitro and in vivo. Biochem Cell Biol 69(10–11):747–750. https://doi.org/10.1139/o91-113
Kim TH, Ku SK, Lee IC, Bae JS (2012) Anti-inflammatory functions of purpurogallin in LPS-activated human endothelial cells. BMB Rep 45(3):200–205
Chang CZ, Lin CL, Wu SC, Kwan AL (2014) Purpurogallin, a natural phenol, attenuates high-mobility group box 1 in subarachnoid hemorrhage induced vasospasm in a rat model. Int J Vasc Med 2014:254270. https://doi.org/10.1155/2014/254270
de Correia Sousa M, Gjorgjieva M, Dolicka D, Sobolewski C, Foti M (2019) Deciphering miRNAs’ action through miRNA Editing. Int J Mol Sci 20(24):6249. https://doi.org/10.3390/ijms20246249
Huang L, Ma Q, Li Y, Li B, Zhang L (2018) Inhibition of microRNA-210 suppresses pro-inflammatory response and reduces acute brain injury of ischemic stroke in mice. Exp Neurol 300:41–50. https://doi.org/10.1016/j.expneurol.2017.10.024
Dong H, Cui B, Hao X (2019) MicroRNA-22 alleviates inflammation in ischemic stroke via p38 MAPK pathways. Mol Med Rep 20(1):735–744. https://doi.org/10.3892/mmr.2019.10269
Liu F, Qiu F, Chen H (2021) miR-124-3p ameliorates isoflurane-induced learning and memory impairment via targeting STAT3 and inhibiting neuroinflammation. NeuroImmunoModulation 13:1–7. https://doi.org/10.1159/000515661
Huang S, Ge X, Yu J, Han Z, Yin Z, Li Y, Chen F, Wang H, Zhang J, Lei P (2018) Increased miR-124-3p in microglial exosomes following traumatic brain injury inhibits neuronal inflammation and contributes to neurite outgrowth via their transfer into neurons. FASEB J 32(1):512–528. https://doi.org/10.1096/fj.201700673R
Dou Y, Tian X, Zhang J, Wang Z, Chen G (2018) Roles of TRAF6 in central nervous system. Curr Neuropharmacol 16(9):1306–1313. https://doi.org/10.2174/1570159X16666180412094655
Lu Y, Cao DL, Ma LJ, Gao YJ (2022) TRAF6 contributes to CFA-induced spinal microglial activation and chronic inflammatory pain in mice. Cell Mol Neurobiol 42(5):1543–1555. https://doi.org/10.1007/s10571-021-01045-y
Wang S, Zhang X, Zhai L, Sheng X, Zheng W, Chu H, Zhang G (2018) Atorvastatin attenuates cognitive deficits and neuroinflammation induced by Aβ1-42 involving modulation of TLR4/TRAF6/NF-κB pathway. J Mol Neurosci 64(3):363–373. https://doi.org/10.1007/s12031-018-1032-3
Li T, Qin JJ, Yang X, Ji YX, Guo F, Cheng WL, Wu X, Gong FH, Hong Y, Zhu XY, Gong J, Wang Z, Huang Z, She ZG, Li H (2017) The ubiquitin E3 ligase TRAF6 exacerbates ischemic stroke by ubiquitinating and activating Rac1. J Neurosci 37(50):12123–12140. https://doi.org/10.1523/JNEUROSCI.1751-17.2017
Liang YP, Liu Q, Xu GH, Zhang J, Chen Y, Hua FZ, Deng CQ, Hu YH (2019) The lncRNA ROR/miR-124-3p/TRAF6 axis regulated the ischaemia reperfusion injury-induced inflammatory response in human cardiac myocytes. J Bioenergy Biomembr 51(6):381–392. https://doi.org/10.1007/s10863-019-09812-9
Zhang BY, Wang GR, Ning WH, Liu J, Yang S, Shen Y, Wang Y, Zhao MX, Li L (2020) Electroacupuncture pretreatment elicits tolerance to cerebral ischemia/reperfusion through inhibition of the GluN2B/m-calpain/p38 MAPK proapoptotic pathway. Neural Plast 2020:8840675
Ren Y, Ma X, Wang T, Cheng B, Ren L, Dong Z, Liu H (2021) The cerebroprotein hydrolysate-I plays a neuroprotective effect on cerebral ischemic stroke by inhibiting MEK/ERK1/2 signaling pathway in rats. Neuropsychiatr Dis Treat 17:2199–2208. https://doi.org/10.2147/NDT.S313807
Huang D, Zhou J, Li W, Zhang L, Wang X, Liu Q (2021) Casticin protected against neuronal injury and inhibited the TLR4/NF-κB pathway after middle cerebral artery occlusion in rats. Pharmacol Res Perspect 9(2):e00752. https://doi.org/10.1002/prp2.752
Song F, Zeng K, Liao L, Yu Q, Tu P, Wang X (2016) Schizandrin A inhibits microglia-mediated neuroninflammation through inhibiting TRAF6-NF-κB and Jak2-Stat3 signaling pathways. PLoS ONE 11(2):e0149991. https://doi.org/10.1371/journal.pone.0149991
Akella A, Bhattarai S, Dharap A (2019) Long noncoding RNAs in the pathophysiology of ischemic stroke. Neuromol Med 21(4):474–483. https://doi.org/10.1007/s12017-019-08542-w
Xu S, Lu J, Shao A, Zhang JH, Zhang J (2020) Glial cells: role of the immune response in ischemic stroke. Front Immunol 11:294. https://doi.org/10.3389/fimmu.2020.00294
Ma Y, Wang J, Wang Y, Yang GY (2017) The biphasic function of microglia in ischemic stroke. Prog Neurobiol 157:247–272. https://doi.org/10.1016/j.pneurobio.2016.01.005
Jiang CT, Wu WF, Deng YH, Ge JW (2020) Modulators of microglia activation and polarization in ischemic stroke (Review). Mol Med Rep 21(5):2006–2018. https://doi.org/10.3892/mmr.2020.11003
He Y, Gao Y, Zhang Q, Zhou G, Cao F, Yao S (2020) IL-4 switches microglia/macrophage M1/M2 polarization and alleviates neurological damage by modulating the JAK1/STAT6 pathway following ICH. Neuroscience 437:161–171. https://doi.org/10.1016/j.neuroscience.2020.03.008
Wang J, Xing H, Wan L, Jiang X, Wang C, Wu Y (2018) Treatment targets for M2 microglia polarization in ischemic stroke. Biomed Pharmacother 105:518–525. https://doi.org/10.1016/j.biopha.2018.05.143
Zhao R, Ying M, Gu S, Yin W, Li Y, Yuan H, Fang S, Li M (2019) Cysteinyl leukotriene receptor 2 is involved in inflammation and neuronal damage by mediating microglia M1/M2 polarization through NF-κB pathway. Neuroscience 422:99–118. https://doi.org/10.1016/j.neuroscience.2019.10.048
Xie X, Zu X, Liu F, Wang T, Wang X, Chen H, Liu K, Wang P, Liu F, Zheng Y, Bode AM, Dong Z, Kim DJ (2019) Purpurogallin is a novel mitogen-activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivo. Mol Carcinog 58(7):1248–1259. https://doi.org/10.1002/mc.23007
Ku SK, Bae JS (2014) Antiplatelet and antithrombotic activities of purpurogallin in vitro and in vivo. BMB Rep 47(7):376–381. https://doi.org/10.5483/bmbrep.2014.47.7.195
Sugiyama H, Fung KP, Wu TW (1993) Purpurogallin as an antioxidant protector of human erythrocytes against lysis by peroxyl radicals. Life Sci 53(4):PL39–PL43. https://doi.org/10.1016/0024-3205(93)90759-v
Park HY, Kim TH, Kim CG, Kim GY, Kim CM, Kim ND, Kim BW, Hwang HJ, Choi YH (2013) Purpurogallin exerts anti-inflammatory effects in lipopolysaccharide-stimulated BV2 microglial cells through the inactivation of the NF-κB and MAPK signaling pathways. Int J Mol Med 32(5):1171–1178. https://doi.org/10.3892/ijmm.2013.1478
Zhao SC, Ma LS, Chu ZH, Xu H, Wu WQ, Liu F (2017) Regulation of microglial activation in stroke. Acta Pharmacol Sin 38(4):445–458. https://doi.org/10.1038/aps.2016.162
Zhao P, Li C, Chen B, Sun G, Chao H, Tu Y, Bao Z, Fan L, Du X, Ji J (2020) Up-regulation of CHMP4B alleviates microglial necroptosis induced by traumatic brain injury. J Cell Mol Med 24(15):8466–8479. https://doi.org/10.1111/jcmm.15406
Liu R, Liao XY, Tang JC, Pan MX, Chen SF, Lu PX, Lu LJ, Zhang ZF, Zou YY, Bu LH, Qin XP, Wan Q (2019) BpV(pic) confers neuroprotection by inhibiting M1 microglial polarization and MCP-1 expression in rat traumatic brain injury. Mol Immunol 112:30–39. https://doi.org/10.1016/j.molimm.2019.04.010
Liu N, Sun H, Li X, Cao W, Peng A, Dong S, Yu Z (2021) Downregulation of lncRNA KCNQ1OT1 relieves traumatic brain injury induced neurological deficits via promoting “M2” microglia polarization. Brain Res Bull 171:91–102. https://doi.org/10.1016/j.brainresbull.2021.03.004
Jiang GL, Yang XL, Zhou HJ, Long J, Liu B, Zhang LM, Lu D (2021) cGAS knockdown promotes microglial M2 polarization to alleviate neuroinflammation by inhibiting cGAS-STING signaling pathway in cerebral ischemic stroke. Brain Res Bull 171:183–195. https://doi.org/10.1016/j.brainresbull.2021.03.010
Min W, Wu Y, Fang Y, Hong B, Dai D, Zhou Y, Liu J, Li Q (2022) Bone marrow mesenchymal stem cells-derived exosomal microRNA-124-3p attenuates hypoxic-ischemic brain damage through depressing tumor necrosis factor receptor associated factor 6 in newborn rats. Bioengineered 13(2):3194–3206. https://doi.org/10.1080/21655979.2021.2016094
Vuokila N, Aronica E, Korotkov A, van Vliet EA, Nuzhat S, Puhakka N, Pitkänen A (2020) Chronic regulation of miR-124-3p in the perilesional cortex after experimental and human TBI. Int J Mol Sci 21(7):2418. https://doi.org/10.3390/ijms21072418
Fang Y, Hong X (2021) miR-124-3p inhibits microglial secondary inflammation after basal ganglia hemorrhage by targeting TRAF6 and repressing the activation of NLRP3 inflammasome. Front Neurol 3(12):653321. https://doi.org/10.3389/fneur.2021.653321
Juźwik CA, Drake S, Zhang Y, Paradis-Isler N, Sylvester A, Amar-Zifkin A, Douglas C, Morquette B, Moore CS, Fournier AE (2019) microRNA dysregulation in neurodegenerative diseases: a systematic review. Prog Neurobiol 182:101664. https://doi.org/10.1016/j.pneurobio.2019.101664
Schindler CR, Woschek M, Vollrath JT, Kontradowitz K, Lustenberger T, Störmann P, Marzi I, Henrich D (2020) miR-142-3p expression is predictive for severe Traumatic Brain Injury (TBI) in trauma patients. Int J Mol Sci 21(15):5381. https://doi.org/10.3390/ijms21155381
Vuokila N, Lukasiuk K, Bot AM, van Vliet EA, Aronica E, Pitkänen A, Puhakka N (2018) miR-124-3p is a chronic regulator of gene expression after brain injury. Cell Mol Life Sci 75(24):4557–4581. https://doi.org/10.1007/s00018-018-2911-z
He XW, Shi YH, Liu YS, Li GF, Zhao R, Hu Y, Lin CC, Zhuang MT, Su JJ, Liu JR (2019) Increased plasma levels of miR-124-3p, miR-125b-5p and miR-192-5p are associated with outcomes in acute ischaemic stroke patients receiving thrombolysis. Atherosclerosis 289:36–43. https://doi.org/10.1016/j.atherosclerosis.2019.08.002
Leung LY, Chan CP, Leung YK, Jiang HL, Abrigo JM, de Wang F, Chung JS, Rainer TH, Graham CA (2014) Comparison of miR-124-3p and miR-16 for early diagnosis of hemorrhagic and ischemic stroke. Clin Chim Acta 10(433):139–144. https://doi.org/10.1016/j.cca.2014.03.007
Xu SY, Jiang XL, Liu Q, Xu J, Huang J, Gan SW, Lu WT, Zhuo F, Yang M, Sun SQ (2019) Role of rno-miR-124-3p in regulating MCT1 expression in rat brain after permanent focal cerebral ischemia. Genes Dis 6(4):398–406. https://doi.org/10.1016/j.gendis.2019.01.002
Gao W, Yang H (2019) MicroRNA-124-3p attenuates severe community-acquired pneumonia progression in macrophages by targeting tumor necrosis factor receptor-associated factor 6. Int J Mol Med 43(2):1003–1010. https://doi.org/10.3892/ijmm.2018.4011
Huo Y, Zhang K, Zhang T, Han Y, Hu Z (2021) MiR-124-3p alleviates the dezocine tolerance against pain by regulating TRAF6 in a rat model. NeuroReport 32(1):44–51. https://doi.org/10.1097/WNR.0000000000001559
Yang Y, Tan X, Xu J, Wang T, Liang T, Xu X, Ma C, Xu Z, Wang W, Li H, Shen H, Li X, Dong W, Chen G (2020) Luteolin alleviates neuroinflammation via downregulating the TLR4/TRAF6/NF-κB pathway after intracerebral hemorrhage. Biomed Pharmacother 126:110044
Cui Y, Wang Y, Zhao D, Feng X, Zhang L, Liu C (2018) Loganin prevents BV-2 microglia cells from Aβ1-42 -induced inflammation via regulating TLR4/TRAF6/NF-κB axis. Cell Biol Int 42(12):1632–1642. https://doi.org/10.1002/cbin.11060
Zhu S, Tang S, Su F (2018) Dioscin inhibits ischemic stroke-induced inflammation through inhibition of the TLR4/MyD88/NF-κB signaling pathway in a rat model. Mol Med Rep 17(1):660–666. https://doi.org/10.3892/mmr.2017.7900
Acknowledgements
Not applicable.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
Conceptualization & Methodology: ZC; Formal analysis and investigation: ZC, XL, XY; Data curation & Resources: RY, YD; Writing—review and editing: ZC. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interest
The authors have no relevant financial or non-financial interests to disclose.
Ethical Approval
Our study was approved by the Ethics Review Board of Nanchang First Hospital.
Consent to Participate and Publish
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
11064_2022_3752_MOESM1_ESM.tif
Supplementary file1 Supplementary figure 1: PPG repressed neuronal apoptosis induced by microgliaA: The conditioned medium. B: CCK8 assay measured neuronal apoptosis. C: Western blot confirmed the protein profiles of pro-apoptotic proteins (Bax, Bad, and C-caspase3) in HT22 neurons. (TIF 1138 kb)
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Cheng, Z., Li, X., Ye, X. et al. Purpurogallin Reverses Neuronal Apoptosis and Enhances “M2” Polarization of Microglia Under Ischemia via Mediating the miR-124-3p/TRAF6/NF-κB Axis. Neurochem Res 48, 375–392 (2023). https://doi.org/10.1007/s11064-022-03752-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-022-03752-4